Shareholders meeting

Date: 18th July, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Subject: Submission of Notice of the 66th Annual General Meeting. Dear Sir/Madam, In terms of the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the Notice convening the 66th Annual General Meeting (“AGM”) of Anuh Pharma Limited scheduled to be held on Wednesday, 12th August, 2026 at 04:00 p.m. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). The Notice of the AGM is also being circulated electronically to the Members of the Company and has been made available on the Company's website. Kindly take the above on your record. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Encl: As above NOTICE Notice is hereby given that the Sixty-Sixth (66th) Annual General Meeting (“AGM”) of the Members of ANUH PHARMA LIMITED (“the Company”) will be held on Wednesday, 12th August, 2026 at 04:00 PM through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) facility to transact the following business. The venue of this AGM shall be deemed to be the Registered Office of the Company at 3-A, Shivsagar Estate, North Wing, Dr. Annie Besant Road, Worli, Mumbai – 400 018 to transact the following business: ORDINARY BUSINESS: Item No. 1 - Adoption of Audited Financial Statements To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended 31st March, 2026, together with the Reports of the Board of Directors and Auditors thereon. Item No. 2 - Declaration of Dividend To declare a Dividend of Rs. 1.50/- per Equity Share of the face value Rs. 5/- each for the Financial Year 2025-26. Item No. 3 - Re-Appointment of a Director retiring by rotation To appoint a Director in the place of Mr. Bipin Nemchand Shah (DIN: 00083244) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013 and, being eligible, seeks re-appointment. Item No. 4 - Re-Appointment of a Director retiring by rotation To appoint a Director in the place of Mr. Arun Lalchand Todarwal (DIN: 00020916) who retires by rotation in terms of Section 152 (6) of the Companies Act, 2013 and, being eligible, seeks re-appointment. SPECIAL BUSINESS: Item No. 5 - Ratification of remuneration of Cost Auditor. To consider and, if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148(3) and other applicable provisions, if any, of the Companies Act, 2013 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force), read with the Companies (Audit and Auditors) Rules, 2014 as amended from time to time, the company hereby ratifies the remuneration of upto Rs. 1,50,000/- (upto Rupees One Lakh Fifty Thousand Only) plus applicable tax and reimbursement of the out of pocket expenses, if any, payable to Mr. Ankit Kishor Chande, Cost Accountants, (Certificate of Practice No. 34051), who have been appointed by the Board of Directors on the recommendation of the Audit Committee, as the Cost Auditors of the Company, to conduct the audit of the Cost records related to Bulk Drugs maintained by the company for the Financial Year ending March, 2025. RESOLVED FURTHER THAT Mr. Bipin Shah, Vice Chairman (DIN: 00083244), Mr. Ritesh Shah (DIN: 02496729), Mr. Vivek Shah (DIN: 02878724), Joint Managing Directors, Mr. Bharat Shah (DIN: 00083354), Mr. Ketan Shah (DIN: 00083326), Directors, or the Company Secretary of the Company be and are hereby severally authorized to take all necessary steps and actions, do all such acts, deeds and things, and sign and file necessary forms, returns or documents, including e-Forms with the Registrar of Companies, to give effect to this resolution.” Item No. 6 - Revision in remuneration payable to Mr. Ritesh B. Shah (DIN: 02496729), Joint Managing Director of the Company for the financial year 2026-27. To consider and, if thought fit, to pass, with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Section 197 read with Part I and Section I of Part II of Schedule V and other applicable provisions, if any, of the Companies Act, 2013 (including any statutory modification(s) or re- enactment(s) thereof, for the time being in force), applicable clauses of the Articles of Association of the Company and the recommendation of the Nomination and Remuneration Committee and as agreed by the Board of Directors, approval of the Members be and is hereby accorded for revision in the remuneration of Mr. Ritesh B. Shah (DIN: 02496729), Joint Managing Director of the Company for the financial year 2026-27, on the terms and conditions including remuneration as mentioned below w.e.f. 01st April, 2026: Monthly CTC of ₹ 4,10,000/- with such increments as may be decided by the Board subject to a ceiling of ₹ 5,00,000/-per month. Commission on net profit before tax - at such rate as may be decided by the Board of Directors from time to time subject to a maximum of 0.50%. Part A 1. Medical Reimbursement - Expenses incurred for self and family, including dependent parents subject to a ceiling of one month’s salary in a year or three month’s salary over a period of three years. 2. Leave Travel Concession - For Self and family once a year incurred in accordance with the rules of the Company. 3. Personal Accident Insurance - Premium not exceeding 15,000/- p.a. 4. Entertainment Expenses - Reimbursement of entertainment expenses actually incurred in the course of business of the Company. Part B a. Provident Fund: Company’s contribution subject to a ceiling as laid down by the Government from time to time. b. Gratuity: Gratuity payable shall not exceed half a month’s salary for each completed year of service and which shall be subject to the maximum amount as may be permitted under the Company’s rules in relation to Gratuity prevailing from time to time. Part C The Company shall provide a car with a driver and a telephone at his residence. The Joint Managing Director shall be entitled to earned privilege leave on full pay and allowances as per rules of the company but not more than one month’s leave for every eleven months of service. The accumulated leaves can be encashed at the end of the service. RESOLVED FURTHER THAT Mr. Bipin Shah, Vice Chairman (DIN: 00083244), Mr. Vivek Shah (DIN: 02878724), Joint Managing Directors, Mr. Bharat Shah (DIN: 00083354), Mr. Ketan Shah (DIN: 00083326), Directors, or the Company Secretary of the Company be and are hereby severally authorized to take all necessary steps and actions, do all such acts, deeds and things, and sign and file necessary forms, returns or documents, including e-Forms with the Registrar of Companies, to give effect to this resolution.” Item No. 7 - Revision in remuneration payable to Mr. Vivek Shah (DIN: 02878724), Joint Managing Director of the Company for the financial year 2026-27. To consider and, if thought fit, to pass, with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Section 197 read with Part I and Section I of Part II of Schedule V and other applicable provisions, if any, of the Companies Act, 2013 (including any statutory modification(s) or re- enactment(s) thereof, for the time being in force), applicable clauses of the Articles of Association of the Company and the recommendation of the Nomination and Remuneration Committee and as agreed by the Board of Directors, approval of [Showing first 8,000 characters — download PDF for full document]